组蛋白去乙酰化酶抑制剂联合依西美坦治疗HR+/HER2-晚期转移性乳腺癌有效性和安全性的Meta分析

李硕, 杨芷轩, 巩文琳, 郄宏鑫, 王培源, 高笑男, 高敬林, 王明霞

A meta-analysis of the efficacy and safety of HDAC inhibitors combined with exemestane in the treatment of HR+/HER2- advanced Metastatic breast cancer

LI Shuo, YANG Zhi-xuan, GONG Wen-lin, QIE Hong-xin, WANG Pei-yuan, GAO Xiao-nan, GAO Jing-lin, WANG Ming-xia

中国新药杂志 . 2026, (18): 1999 -2008 . DOI: 10.20251/j.cnki.1003-3734.2026.18.012